Steven Cohen Esperion Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$36 Billion
Q2 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 67,070 shares of ESPR stock, worth $112,677. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,070

Previous 67,070 -0.0%

Holding current value

$112,677

Previous $148,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $93,840 - $165,240	51,000 Added 317.36%	67,070 $148,000
Q1 2024 May 15, 2024	BUY	$2.02 - $3.02 $22,765 - $34,035	11,270 Added 234.79%	16,070 $43,000
Q4 2023 Feb 14, 2024	SELL	$0.73 - $3.08 $2.26 Million - $9.53 Million	-3,093,052 Reduced 99.85%	4,800 $14,000
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $1.8 Million - $3.36 Million	-1,877,148 Reduced 37.73%	3,097,852 $3.04 Million
Q2 2023 Aug 14, 2023	BUY	$1.2 - $1.76 $1.65 Million - $2.42 Million	1,375,000 Added 38.19%	4,975,000 $6.92 Million
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $1.93 Million - $9.66 Million	1,323,000 Added 58.1%	3,600,000 $5.72 Million
Q4 2022 Feb 14, 2023	SELL	$5.09 - $8.5 $2.6 Million - $4.35 Million	-511,300 Reduced 18.34%	2,277,000 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $9.4 Million - $14 Million	1,725,204 Added 162.28%	2,788,300 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $5.07 Million - $7.09 Million	1,063,096 New	1,063,096 $6.76 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $28.71 $12.6 Million - $18.6 Million	-648,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.12 - $36.89 $16.3 Million - $23.9 Million	648,200 New	648,200 $18.2 Million
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $131,712 - $354,432	-4,800 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $14.7 Million - $24.8 Million	-414,590 Reduced 98.86%	4,800 $286,000
Q3 2019 Nov 15, 2019	BUY	$34.47 - $47.53 $12.2 Million - $16.8 Million	352,617 Added 528.08%	419,390 $15.4 Million
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $6.03 Million - $7.87 Million	-150,327 Reduced 69.24%	66,773 $3.11 Million
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $8.71 Million - $11.6 Million	217,100 New	217,100 $8.72 Million
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $18.8 Million - $30 Million	-507,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $5.83 Million - $7.36 Million	143,200 Added 39.33%	507,300 $22.5 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $13.2 Million - $27.8 Million	364,100 New	364,100 $14.3 Million

Others Institutions Holding ESPR

# of Institutions

199

Shares Held

136M

Call Options Held

2.72M

Put Options Held

1.3M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $112M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account